ArticleFrontiers in immunology2021

Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide.

Lili Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.